Showing 504 results

Filters Content type: News, Editors' picks, About HIV Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Sexually transmitted infections epidemiology

'Super-gonorrhoea' outbreak across north of England sparks national alert

Editor's pick
Daily Telegraph
18 September 2015
Sexually transmitted infections tests & treatment

Can we ensure adherence to STI treatment guidelines in a world threatened by antimicrobial resistance?

Editor's pick
BMJ
26 August 2015
Resistance

Pretreatment HIV drug resistance leads patients to switch to second-line ART

Editor's pick
Healio
11 August 2015
Pregnancy and vertical transmission

Raltegravir appears to prevent mother-to-child HIV transmission during late pregnancy

News
28 July 2015
Resistance

Transmitted HIV drug resistance is persistent but is not harming treatment responses in the UK

News
3 June 2015
HIV treatment for children & young people

High treatment failure rate among Thai children switching to second-line ART

News
20 April 2015
Resistance

Limited Number of Mutations Responsible for Drug-Resistant HIV

Editor's pick
Genetic Engineering & Biotechnology News
8 April 2015
Resistance

Exploring possible treatment options after virological failure with raltegravir

Editor's pick
CATIE
21 January 2015
New & experimental HIV treatments

New anti HIV drug dolutegravir is effective at low doses

Editor's pick
MMD Newswire
21 January 2015
PrEP

Drug Resistance, While Rare, Can Occur After Contracting HIV on PrEP

Editor's pick
AIDSMeds
16 January 2015
Resistance

Drug-resistant infections could lead to 10 million extra deaths a year – report

Editor's pick
The Guardian
11 December 2014
Undetectable viral load & treatment as prevention

What are the barriers that could stop HIV treatment becoming HIV prevention?

News
12 November 2014
Changing treatment

Protease inhibitor monotherapy: darunavir/ritonavir less effective than three-drug therapy

News
7 November 2014
Injectable & long-acting PrEP

Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex

News
1 November 2014
Resistance

Emerging epidemic of transmitted HIV drug resistance in low- and middle-income countries, with highest burden seen in MSM

News
28 October 2014
Resistance

Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs

News
9 September 2014
HIV treatment

Dolutegravir demonstrates good efficacy despite resistance

News
24 July 2014
HIV treatment for children & young people

High rates of drug resistance among HIV-positive infants in South Africa

News
13 July 2014
Changing treatment

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

News
9 June 2014
TB treatment

An activist's guide to TB drugs

Editor's pick
TAG
4 June 2014
PrEP science

No significant risk of resistance if HIV infection occurs during use of Truvada PrEP

News
13 May 2014
Epidemiology

Transmitted HIV Resistance Rate Close to 20% in Large Study of US MSM

Editor's pick
NATAP
6 March 2014
Young people

Average CD4 cell count at time HIV therapy was started increased among young people in New York City after 2009

News
29 January 2014
Resistance

Successful HIV drug resistance testing is possible when viral load is low

News
27 January 2014